1. Medtech Insight
  2. >>Device Area

Market Intel: Intense Competition, Innovation Drive Healing Trends In Wound Care

 
• By Carrie Neptune

The global advanced wound-care market is expected to reach $10.4bn by 2020, driven by massive competition, and forcing companies to innovate constantly to address the rising prevalence of chronic wound injuries, diabetic foot ulcers and burns. While regulatory and reimbursement challenges prevail, opportunities in this highly segmented market, in particular, in the advanced wound-dressings sector, are vast, with double-digit revenue growth potential.

wound dressing equipment flat set

Major advances in the understanding of the basic science behind wound healing have led to an explosion in new wound-care technologies and improvements in existing products. This article delves into the competitive landscape for a variety of wound-care techniques – including advanced wound dressings, tissue-engineered skin replacements, active wound-repair modulators, advanced wound-closure technologies, surgical sealants and automated suturing devices. And it addresses the factors that are driving, or impeding, the widespread adoption of these products.

Global sales of advanced wound dressings are expected to hit $4bn by 2020; foam wound dressings represent both the largest product segment and the most significant growth driver for the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Wound Management

More from Device Area

Pathogen Sharing System Part Of Global Pandemic Agreement

 
• By Neena Brizmohun

Now that the landmark Pandemic Agreement has finally been adopted, work will start on drafting a pathogen access and benefit sharing system that will be voluntary for use by drug companies.

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.